LOGIN
Knee OA: MRI assessments reveal early effect of chondroitin sulphate on cartilage loss
February 2014
Knee OA: MRI assessments reveal early effect of chondroitin sulphate on cartilage loss
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
Ann Rheum Dis. 2011 Jun;70(6):982-9. doi: 10.1136/ard.2010.140848. Epub 2011 Mar 1Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
70 patients with primary knee osteoarthritis were randomized to receive either 800 mg chondroitin sulphate (CS) or a placebo once a day for 6 months to determine the effects of CS on joint cartilage, assessed using magnetic resonance imaging (MRI). Results revealed that 800 mg chondroitin sulphate had an early effect (6 months) on cartilage volume loss and on bone marrow lesions at 12 months. Addi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.